Innovative research projects aim to transform CLL/SLL patient outcomes SAN DIEGO , July 23, 2024 /PRNewswire/ -- CLL Society , the world's leading authority for chronic lymphocytic leukemia and small lymphocytic lymphoma patients, has announced the recipients of its 2024 Research Program awards. This year, four distinguished researchers have been recognized across various categories including the Integrative Medicine Award, Clinical Scholar Award and Young Investigator Award. CLL Society is dedicated to transforming the lives of patients through groundbreaking research, patient support and advocacy.
The Research Program awards are a critical component of this mission, supporting innovative projects that aim to improve the health outcomes for those affected by chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL). This year's awards highlight significant contributions in the fields of integrative medicine, clinical research and emerging scientific investigations The 2024 Research Program recipients are as follows: Integrative Medicine Awards: This category supports innovative research projects that study the mechanistic basis or clinical outcomes related to the use of integrative medicine therapies, specifically for those living with CLL and SLL. Two researchers have been honored this year: Dr.
Christopher Jensen from the University of North Carolina at Chapel Hill has been awarded the Integrative Medicine Award for his project, "Combating Cancer-Related Fati.
